NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
23 October 2024
| Name: | PHYLOGICA LIMITED (PYC) (This company subsequently changed its name to PYC THERAPEUTICS LIMITED. You should refer to that name for Status.) | ||||||
| Date of Listing: | 30 March 2005 | ||||||
| Subsequent Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to PYC THERAPEUTICS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to PYC THERAPEUTICS LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now PYC THERAPEUTICS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| PYC THERAPEUTICS LIMITED | 28/11/2019 | |
| PHYLOGICA LIMITED | 28/11/2019 |
Security Transfer Australia Pty Ltd
No longer operating
Expand this box to read and print
name changed to PYC Therapeutics Limited | 28/11/2019 |
The suspension of trading in the securities of Phylogica Limited will be lifted from the commencement of trading today, Wednesday, 12 September 2018, following the release by PYC of an announcement regarding a capital raising. | 12/09/2018 |
The company has received firm commitments to raise $9.12 m (before costs) through a placement of shares to both new and existing sophisticated and institutional investors at a price of 3 cents per new security. The placement will occur in two tranches. | 12/09/2018 |
The company's capital raising is conducted at a price of 3 cents per share. It is an excluded offer available to professional investors only and will introduce new sophisticated and institutional investors to Phylogica's register. This is being supported by the company's existing major shareholders and will provide funding for 3 primary activities. | 11/09/2018 |
The securities of Phylogica Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of PYC, pending the release of an announcement regarding a capital raising. | 11/09/2018 |
shares reinstated to quotation | 18/08/2010 |
company advises that the signing of formal documentation with a large pharmaceutical and biotechnology group regarding a new research partnership utilizing the Company's proprietary library of protein fragments (Phylomer peptides) is now imminent | 16/08/2010 |
company says it believes it will have enough cash to finance activities over the next two quarters | 09/08/2010 |
shares suspended from quotation pending release of an announcement | 05/08/2010 |
the suspension of trading in the securities of Phylogica Limited (the "Company") will be lifted immediately following receipt of an announcement by the Company | 08/12/2009 |
shares suspended from quotation pending release of an announcement | 03/12/2009 |
shares reinstated to quotation | 31/08/2006 |
shares suspended from quotation pending release of an announcement | 29/08/2006 |
name changed to PYC Therapeutics Limited | 28/11/2019 |
The suspension of trading in the securities of Phylogica Limited will be lifted from the commencement of trading today, Wednesday, 12 September 2018, following the release by PYC of an announcement regarding a capital raising. | 12/09/2018 |
The company has received firm commitments to raise $9.12 m (before costs) through a placement of shares to both new and existing sophisticated and institutional investors at a price of 3 cents per new security. The placement will occur in two tranches. | 12/09/2018 |
The company's capital raising is conducted at a price of 3 cents per share. It is an excluded offer available to professional investors only and will introduce new sophisticated and institutional investors to Phylogica's register. This is being supported by the company's existing major shareholders and will provide funding for 3 primary activities. | 11/09/2018 |
The securities of Phylogica Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of PYC, pending the release of an announcement regarding a capital raising. | 11/09/2018 |
shares reinstated to quotation | 18/08/2010 |
company advises that the signing of formal documentation with a large pharmaceutical and biotechnology group regarding a new research partnership utilizing the Company's proprietary library of protein fragments (Phylomer peptides) is now imminent | 16/08/2010 |
company says it believes it will have enough cash to finance activities over the next two quarters | 09/08/2010 |
shares suspended from quotation pending release of an announcement | 05/08/2010 |
the suspension of trading in the securities of Phylogica Limited (the "Company") will be lifted immediately following receipt of an announcement by the Company | 08/12/2009 |
shares suspended from quotation pending release of an announcement | 03/12/2009 |
shares reinstated to quotation | 31/08/2006 |
shares suspended from quotation pending release of an announcement | 29/08/2006 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 12/04/2019 | Alan Tribe | 300,000 | $0.025 | $7,500 |
| 14/10/2016 | Bernard Hockings | 3,000,000 | $0.006 | $17,000 |
| 10/10/2016 | Bernard Hockings | 3,000,000 | $0.015 | $46,219 |
| 10/08/2015 | Bernard Hockings | -18,631,578 | $0.010 | $186,315 |
| 30/07/2015 | Bernard Hockings | -2,679,822 | $0.001 | $2,680 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Alan Tribe | Non Exec Chairman | 11/04/2018 |
| Kevin Hart | CFO, Company Secretary | 24/07/2017 |
| Bernard Hockings | Non Exec Director | 24/01/2014 |
| Rohan Hockings | Director, CEO | 15/08/2016 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Sahm Nasseri | Non Exec Director | 23/10/2017 | 11/02/2019 |
| Robert Hayes | Executive Director | 18/04/2017 | 30/11/2018 |
| Stephanie Unwin | Non Exec Director, CEO | 18/01/2016 | 27/04/2018 |
| Michael Williams | Non Exec Director | 03/01/2018 | 11/04/2018 |
| Paul Watt | Non Exec Director | 09/08/2002 | 24/11/2017 |
| Rick Kendall | Independent Director | 18/04/2017 | 23/10/2017 |
| Graeme Boden | CFO | 19/07/2013 | 24/07/2017 |
| Jeremy Cook | Non Exec Director | 01/03/2012 | 18/04/2017 |
| Douglas Wilson | Non Exec Director | 10/12/2007 | 25/11/2016 |
| Richard Hopkins | CEO | 19/07/2013 | 01/10/2016 |
| Bruce McHarrie | Non Exec Chairman | 09/08/2002 | 09/04/2016 |
| Nick Woolf | CFO | 22/04/2010 | 19/07/2013 |
| Joachim von Roy | Executive Chairman | 24/08/2004 | 27/05/2009 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
